Methods of healing wounds by administering human IL-18
AssigneeSmithKline Beecham Corporation
InventorsKimberly Dede, Judithann Lee
Life of this patent
Estimating the term…
Abstract
The present invention relates generally to the use of human IL-18, also known as interferon-γ-inducing factor (IGIF), in the treatment of skin wounds, surgical wounds, leg ulcers, diabetic ulcers, gastrointestinal mucositis, oral mucositis, and lung injury.
Claims13
A method of healing a wound in a patient in need thereof, comprising the step of administering to the patient a therapeutically effective amount of human IL-18 polypeptide (SEQ ID NO:1).
The method as claimed in claim 2, wherein the wound is chosen from the group of:
- skin wounds, surgical wounds, leg ulcers, diabetic ulcers, mucositis, and lung injury.
A method of healing a wound in a patient in need thereof, comprising the step of administering to the patient a pharmaceutical composition comprising an effective amount of human IL-18 polypeptide (SEQ ID NO:1) in combination with a carrier.
Dependencies are inferred from the claim text.